key: cord-0928333-mzf839k3
authors: Dong, Mei; Luo, Ming; Li, Aihua; Xie, Hui; Gong, Cheng; Du, Juan; Wang, Xinrui; Li, Maozhong; Wang, Xue; Wang, Yiting; Zhang, Haiyan; Yang, Xiaoxing; Cai, Wei; Li, Hongjun; Zhang, Wenzeng; Ren, Lijun; Lu, Qing-Bin; Huang, Fang
title: Changes in the pathogenic spectrum of acute respiratory tract infections during the COVID-19 epidemic in Beijing, China: A large-scale active surveillance study
date: 2021-08-11
journal: J Infect
DOI: 10.1016/j.jinf.2021.08.013
sha: b6c3390c3da8076c4cd389942c4cd5c70e77d4f1
doc_id: 928333
cord_uid: mzf839k3

nan

All 41630 cases were tested for 11 respiratory tract pathogens and 13630 (32.74%, 95% CI 32.29%-33.19%) had at least one positive result. Before the COVID-19 epidemic, the most common pathogen among the positive cases was IFV, 4   followed by MP, HPIV, HRV, EV, RSV, seasonal HCoV, HMPV, HAdV, HBoV and   CP, which changed to seasonal HCoV, followed by HRV, HPIV, IFV, RSV, EV,   HBoV, HMPV, MP, HAdV and CP During the COVID-19 epidemic (Fig. 1C-F and   Table S1 -S3). SARS-CoV-2 was not detected. For children, the top five pathogens were MP, IFV, HPIV, EV and RSV before the COVID-19 epidemic, changing to HPIV, HCoV, HRV, RSV and IFV. For adults, the top five pathogens were IFV, MP, HRV, HPIV and HCoV before the COVID-19 epidemic, changing to HCoV, HRV, IFV HPIV and EV. All the other pathogens had distinct increases in proportions except for IFV.

Before the COVID-19 epidemic, 12058 (32.16%, 95% CI 31.69%-32.64%)

were positive for at least one pathogen, which significantly dropped to 10.97% (95% CI 10.03%-11.96%) during the COVID-19 epidemic (P<0.001, Fig. 2A and Table   S4 ). The positive rates of the top five pathogens were IFV (9.22%), MP (6. Among all the pathogens, only seasonal HCoV had 20.74% increase in the positive rate, from 2.00% to 2.42% (P=0.073). The other 10 pathogens had significant decreases in their positive rates (all P<0.05). IFV had the largest difference (-7.72%, 95% CI -8.19%, -7.25%) in the positive rate decreasing by 83.75% ( Figure 2B ). 5 In children, a significant increase in HCoV was observed from 1.74% to 3.29% (P=0.002, Fig. 2A,2C and Table S5 ). The positive rates of the top five pathogens were MP (9.37%), IFV (7.43%), HPIV (6.94%), EV (5.09%) and RSV (4.28%) before the COVID-19 epidemic and HPIV (5.26%), HCoV (3.29%), HRV (3.29%), RSV (7). Four seasonal HCoVs showed biennial incidence peaks in winter with alternating peak seasons for 229E and NL63, and OC43 and HKU1. Studies showed a biennial trend on the peak prevalence of seasonal HCoV in Beijing (8, 9) . Therefore, the incidence of seasonal HCoV may 7 have peaked in 2020/2021, which may have been higher without no public measures for COVID-19. This suggests that we need to further strengthen the monitoring of HCoV in the future to prevent a co-epidemic of seasonal HCoV and SARS-CoV-2, especially when control measures for COVID-19 become normalized.

In general, public health measures against COVID-19 substantially reduced the prevalence of other respiratory pathogens. IFV decreased from the first to the fourth during the COVID-19 epidemic. Seasonal HCoV, which became the first pathogen of ARTIs, should be strengthened to control to prevent co-circulation with SARS-CoV-2.

These findings indicated the additional benefits of the public health measures implemented for COVID-19 in reducing the spread of other respiratory diseases. The dot dash grey line represents the min number of samples from ARTI before the epidemic of the COVID-19. The blue column represents the number of the COVID-19 patients using the right vertical axis. 10 C, the pie chart for pathogenic spectrum of acute respiratory tract infections before the COVID-19; D, the pie chart for pathogenic spectrum of acute respiratory tract infections during the COVID-19; E, the column chart for pathogenic spectrum of acute respiratory tract infections before the COVID-19 for the children; F, the column chart for pathogenic spectrum of acute respiratory tract infections before the COVID-19 for the adults.

E-F, the grey column represents the proportion of the pathogen before the COVID-19; the blue column represents the proportion of the pathogen during the COVID-19, which decreased compared to that before the COVID-19; the red column represents the proportion of the pathogen during the COVID-19, which increased compared to that before the COVID-19.

The period between 1 February 2015 and 31 January 2020 for the control was as before the COVID-19 and the period between 1 February 2020 and 31 January 2021 was as during the COVID-19. COVID-19, coronavirus disease 2019. A, the positive rate of the pathogens as a whole and in the children and in the adults; the star means the significant difference between the positive rates before and during the COVID-19 by chi square test; The grey column represents the proportion of the pathogen before the COVID-19; the blue column represents the proportion of the pathogen during the COVID-19, which decreased compared to that before the COVID-19; the red column represents the proportion of the pathogen during the COVID-19, which increased compared to that before the COVID-19; B, the difference (upper half part) and difference proportion (lower half part) between the positive rates before and during the COVID-19 as a whole; C, the difference (upper half part) and difference proportion (lower half part) between the positive rates before and during the COVID-19 in the children; D, the difference (upper half part) and difference proportion (lower half part) between the positive rates before and during the COVID-19 in the adults; B-D, the green column/dot represents the decrease difference/difference proportion; the purple column/dot represents the increase difference/difference proportion; The difference of positive rates was defined as the positive rate during the COVID-19 minus the positive rate before the COVID-19. The difference proportion (%) was defined as the difference of positive rate (%) divided by the detection rate before the COVID-19. 

SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study

Effects of human behaviour changes during the COVID-19 pandemic on influenza spread in Hong Kong

Decreased Influenza Incidence under COVID-19 Control Measures

Effect of Social Distancing Due to the COVID-19 Pandemic on the Incidence of Viral Respiratory Tract Infections in Children in Finland During Early 2020

Pubmed Central PMCID: PMC7498167 Journal Editors form for disclosure of potential conflicts of interest. Cheryl Cohen reports grants from Sanofi Pasteur and non-financial support from Parexel during the conduct of the study

Disappearance of summer influenza in the Okinawa prefecture during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Respir Investig

Virological surveillance of influenza and other respiratory viruses during six consecutive seasons from 2006 to 2012 in Catalonia, Spain

The presence of fever in adults with influenza and other viral respiratory infections

Prevalence of human coronaviruses in adults with acute respiratory tract infections in Beijing